ReviewClinical epigenetics2026
Unveiling the epigenetic landscape: transforming renal cell carcinoma treatment.
Review in Clinical epigenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development and progression of renal cell carcinoma (RCC) are influenced by variety of factors, which pose significant health threats globally. RCC has an atypical clinical presentation and is susceptible to anticancer drug resistance; thus, understanding the mechanisms of RCC formation is necessary. There is growing evidence that RCC is regulated by epigenetic mechanisms, including DNA modifications, histone modifications, noncoding RNAs (ncRNAs) and RNA modifications. Considering the widespread presence of epigenetic mechanisms in RCC, their potential for clinical application has received substantial attention from the scientific community in recent years. Here, we review the articles published in recent years and summarize the properties and functions of epigenetic regulation, with a focus on the impact of the epigenetic regulation on RCC and its potential clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.